Ra Capital Management, L.P. Rhythm Pharmaceuticals, Inc. Transaction History

Ra Capital Management, L.P.

$6.64 Billion
Q2 2024

A detailed history of Ra Capital Management, L.P. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 6,084,412 shares of RYTM stock, worth $302 Million. This represents 3.77% of its overall portfolio holdings.

Number of Shares

6,084,412

Holding current value

$302 Million

% of portfolio

3.77%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$35.41 - $44.37 $215 Million - $270 Million	6,084,412 New	6,084,412 $250 Million
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $114 Million - $265 Million	5,330,412 New	5,330,412 $245 Million
Q2 2023 Aug 14, 2023	BUY	$16.32 - $21.15 $2.61 Million - $3.38 Million	160,000 Added 2.9%	5,676,067 $93.6 Million
Q4 2022 Feb 14, 2023	BUY	$22.21 - $30.25 $999,450 - $1.36 Million	45,000 Added 0.82%	5,516,067 $161 Million
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $2.58 Million - $18.5 Million	600,000 Added 12.32%	5,471,067 $134 Million
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $14 Million - $27.3 Million	692,000 Added 16.56%	4,871,067 $104 Million
Q4 2020 Feb 16, 2021	SELL	$21.17 - $32.61 $20.4 Million - $31.3 Million	-961,341 Reduced 18.7%	4,179,067 $124 Million
Q3 2020 Nov 16, 2020	SELL	$18.13 - $30.61 $1.26 Million - $2.13 Million	-69,680 Reduced 1.34%	5,140,408 $111 Million
Q2 2020 Aug 14, 2020	SELL	$14.41 - $25.35 $3.06 Million - $5.38 Million	-212,224 Reduced 3.91%	5,210,088 $116 Million
Q4 2019 Feb 14, 2020	BUY	$19.53 - $25.5 $39.1 Million - $51 Million	2,000,000 Added 58.44%	5,422,312 $124 Million
Q3 2019 Nov 14, 2019	BUY	$18.62 - $24.51 $28.6 Million - $37.7 Million	1,537,530 Added 81.58%	3,422,312 $73.9 Million
Q1 2019 May 15, 2019	SELL	$24.76 - $31.66 $1.62 Million - $2.08 Million	-65,550 Reduced 3.36%	1,884,782 $51.7 Million
Q3 2018 Nov 14, 2018	BUY	$26.99 - $35.85 $11 Million - $14.6 Million	408,589 Added 26.5%	1,950,332 $56.9 Million
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $26.2 Million - $54.3 Million	1,541,743 New	1,541,743 $48.2 Million

Others Institutions Holding RYTM

# of Institutions

178

Shares Held

69.1M

Call Options Held

467K

Put Options Held

224K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.76B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.

Account

Ra Capital Management, L.P. Rhythm Pharmaceuticals, Inc. Transaction History